Odonate Therapeutics, Inc. Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2021-09-30..
Operating margin
Overview →Financial period ending 2021-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2021-09-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -102.32M USD | Operating Income (Loss) |
| Revenue | (m) | |
| Cost of products and services | (m) | |
| Research and development | 82.50M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2021-09-30 | $-102.32M | (m) | (m) | $82.50M | (m) | (m) |
| 2021-06-30 | $-118.96M | (m) | (m) | $107.87M | (m) | (m) |
| 2021-03-31 | $-130.43M | (m) | (m) | $120.02M | (m) | (m) |
| 2020-12-31 | $-127.43M | (m) | (m) | $117.04M | (m) | (m) |
| 2020-09-30 | $-123.71M | (m) | (m) | $112.82M | (m) | (m) |
| 2020-06-30 | $-120.82M | (m) | (m) | $109.67M | (m) | (m) |
| 2020-03-31 | $-116.53M | (m) | (m) | $105.35M | (m) | (m) |
| 2019-12-31 | $-114.93M | (m) | (m) | $104.03M | (m) | (m) |
| 2019-09-30 | $-115.70M | (m) | (m) | $104.98M | (m) | (m) |
| 2019-06-30 | $-112.56M | (m) | (m) | $101.55M | (m) | (m) |
| 2019-03-31 | $-103.11M | (m) | (m) | $92.12M | (m) | (m) |
| 2018-12-31 | $-90.76M | (m) | (m) | $79.95M | (m) | (m) |
| 2018-09-30 | $-77.03M | (m) | (m) | $66.19M | (m) | (m) |
| 2018-06-30 | $-62.78M | (m) | (m) | $53.65M | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | $39.91M | (m) | (m) |
| 2017-12-31 | $-32.74M | (m) | (m) | $27.90M | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.